Shanler Stuart 4
4 · Aclaris Therapeutics, Inc. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Shanler Stuart
Chief Scientific Officer
Transactions
- Award
Restricted stock units
2019-03-01+82,200→ 82,200 total→ Common Stock (82,200 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The shares underlying these restricted stock units vest in four equal annual installments beginning on March 1, 2020, subject to the Reporting Person's continuous service with the issuer as of the applicable vesting date.